Analysis shows that legal status plays a significant role in a person’s ability to access services.

In his latest op-ed for The Hill, Dr. Jonathan Fielding, professor-in-residence of health policy and management, states that U.S. leadership needs to actively support breastfeeding, both in domestic and international health policy making.

UCLA FSPH's Corrina Moucheraud says policymakers should focus on training health workers, ensuring access to essential medicines.

In his latest op-ed for The Hill, Dr. Jonathan Fielding, professor-in-residence of health policy and management, shares his thoughts about "our government’s responsibility toward those whom they detain or deport and all those with whom they interact."

"In spite of the growing chorus demanding action, it’s difficult to imagine Congress moving soon on firearm safety. Our inability to identify safety measures acceptable to all ideologies assures gridlock, but with Americans 10 times more likely to be killed by guns than people in other developed countries, we simply cannot wait." - Dr. Jonathan Fielding

"We are in the midst of a tooth decay epidemic across the U.S. The implications of that epidemic to children’s health throughout their lives are bad enough that the federal government needs to get involved to secure the future health of America’s children." – Dr. Jonathan Fielding

Gerald Kominski to remain as senior fellow and professor.

Elective hip and knee replacements may represent a significant source of potentially controllable healthcare spending, according to a March 13 Viewpoint article published in the Journal of the American Medical Association (JAMA) and authored by members of the Center for Health Advancement at the UCLA Fielding School of Public Health (FSPH).

It's time to get serious about a universal flu vaccine.

As accelerated aging of different parts of women’s bodies comes to light, new questions are raised about hormone exposure and breast cancer risk.

Capitol Hill's miserable work environment holds a lesson for our own health and well-being.

Pharmaceutical company profits should not outweigh the public interest.